The fight versus Covid-19 took a significant step forward on Friday as the United States moved closer to distributing its very first one-shot Covid-19 vaccine, after an independent professional advisory panel advised drug regulators authorize the Johnson & Johnson vaccine for emergency situation usage.
” We urgently need more vaccines [authorized] to protect the millions of Americans who stay at threat” of Covid-19 infection, said Dr Greg Poland, the editor-in-chief of the medical journal Vaccine and leader of the Vaccine Research Group at the Mayo Clinic.
Johnson & Johnson’s vaccines and the dosages currently set up to be provided by Moderna and Pfizer, the makers of the 2 vaccines currently licensed in the United States, imply there might be sufficient supply to immunize 400 million people by July.
http://allcnaprograms.com/johnson-johnson-one-shot-covid-vaccine-gets-nod-from-fda-advisory-panel/
No comments:
Post a Comment